ITGA2 is highly expressed in pancreatic cancer tissues and correlates with a decreased overall survival (OS) and disease-free survival (DFS) rate in patients with high ITGA2 expression (Supplementary Figure S1). The gene discussed is ITGA2; the disease is familial pancreatic carcinoma.